GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
-15.4%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$287M
AUM Growth
+$287M
(-25%)
Cap. Flow
-$19.6M
Cap. Flow
% of AUM
-6.82%
Top 10 Holdings %
Top 10 Hldgs %
55.29%
Holding
54
New
11
Increased
10
Reduced
15
Closed
11
Top Buys
| 1 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
$12.6M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$12.5M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$11.2M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$10.4M |
| 5 |
Pacira BioSciences
PCRX
|
$9.52M |
Top Sells
| 1 |
Acadia Pharmaceuticals
ACAD
|
$20M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$15.8M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$10.9M |
| 4 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$9.02M |
| 5 |
Ascendis Pharma
ASND
|
$7.22M |
Sector Composition
| 1 | Healthcare | 87.12% |